the

ZAlloy: The Future of Cleveland Golf Wedges

HUNTINGTON BEACH, Calif., July 1, 2025 – From the Cleveland 588 Tour Action to the ground-breaking RTX ZipCore, Cleveland Golf…

12 months ago

Metabolon’s Untargeted Metabolomics Services Used for Breakthrough Study Revealing Powerful Link Between Gut Microbiome, the Metabolome, and Type 2 Diabetes (T2D)

Combining metabolomics, gut microbiome, and clinical data may help prevent and personalize the treatment of type 2 diabetes MORRISVILLE, N.C.,…

12 months ago

FAIR PLAY MENARINI INTERNATIONAL AWARD, LUIS FIGO JOINS THE GREAT SPORTS STARS ACKNOWLEDGED IN 2025

FLORENCE, Italy, July 1, 2025 /PRNewswire/ -- Surprises never end when it comes to the Fair Play Menarini International Award:…

12 months ago

Minelab Unveils the GOLD MONSTER 2000: More Precision. More Depth. More Gold

ADELAIDE, Australia, July 1, 2025 /PRNewswire/ -- Minelab is proud to announce the launch of the GOLD MONSTER 2000, a fully…

12 months ago

TraceLink’s MINT Named “Supply Chain Transparency Solution of the Year” in 2025 SupplyTech Breakthrough Awards

The award recognizes MINT for enabling real-time, end-to-end visibility across critical supply chain transactions and processes BOSTON, July 1, 2025…

12 months ago

IMG Launches First ‘Student Journey Scholarship’ for International Students in the U.S.

INDIANAPOLIS, July 1, 2025 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is…

12 months ago

New Glassnode Report: How Bybit’s Response to the Lazarus Hack Became Crypto’s Defining Stress Test

DUBAI, UAE, July 1, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has been featured in a…

12 months ago

CNRC Announces Change in Control, New Management and the Deployment of the Cutting-Edge KUBERA Technology to Enhance Oil and Gas Detection and Exploration

CHARLESTON, W.Va., July 1, 2025 /PRNewswire/ -- Cunningham Natural Resources Corp (OTC: CNRC) ("CNRC" or the "Company") announced today that Aruna…

12 months ago

Inmagene Doses First Patient in the ADAPTIVE Phase 2b Trial of IMG-007, a Nondepleting Anti-OX40 mAb with an Extended Half-life, in Patients with Moderate-to-Severe Atopic Dermatitis

July 01, 2025 09:00 ET  | Source: Inmagene Biopharmaceuticals The ADAPTIVE Phase 2b trial evaluates multiple dose regimens of IMG-007…

12 months ago

Visory Health Wins Gold at the 2025 Digital Health Awards

ESTERO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Visory Health, a leading patient-first health tech prescription platform that is transforming…

12 months ago